Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Antimycobacterial screening of four series of primaquine derivatives (CROSBI ID 649644)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Jampilek, Josef ; Pospišilova, Sarka ; Michnova , Hana ; Pavić, Kristina ; Perković, Ivana ; Zorc, Branka Antimycobacterial screening of four series of primaquine derivatives // Book of Abstracts / Basarić , Nikola ; Namjesnik, Danijel ; Perković, Ivana et al. (ur.). Zagreb: Hrvatsko kemijsko društvo, 2017. str. 244-244

Podaci o odgovornosti

Jampilek, Josef ; Pospišilova, Sarka ; Michnova , Hana ; Pavić, Kristina ; Perković, Ivana ; Zorc, Branka

engleski

Antimycobacterial screening of four series of primaquine derivatives

Primaquine (PQ) is a well known antimalarial drug active against all species of parasite causing human malaria, including multi- resistant P. falciparum strains. Primaquine has been also identified as orally administrated drug capable of inhibiting M. tuberculosis growth.[1] In several papers, we have described preparation of almost hundred various PQ derivatives and their evaluation as potential antiproliferative, antioxidative, antimalarial, antimicrobial and antiviral agents.[2-7] Here we report the results of antimycobacterial screening of four groups of PQ derivatives: amides 1a-k, ureas 2a-s, semicarbazides 3a-c and bis-ureas 4a-u. Antimycobacterial evaluation was performed in vitro against three different Mycobacterium species: M. tuberculosis H37Ra ATCC 25177 (MTB), well characterised clinical isolates of M. avium complex CIT19/06 (MAC), and M. avium subsp. paratuberculosis CIT03 (MAP). The results were compared with PQ diphosphate and the standard antitubercular drugs isoniazid (INH), rifampicin (RIF) and ciprofloxacin (CPX). Most of the compounds of series 1 and 2 showed high activity against MAP, comparable or even higher than the relevant drug CPX, and weak or no activity against the other two bacteria. Cinnamic acid amide 1a and bis-CF3 cinnamic acid amide 1k were active against all three Mycobacterium species comparable or slightly higher than the reference drugs. PQ urea derivatives 2f-p with hydroxyl, halogen and particularly trifluoromethyl substituted benzene ring exerted very strong antimycobacterial activity towards all three tested bacteria, stronger than PQ and the reference drugs. In general, meta substituted derivatives were more active than analogues para derivatives. The benzene substituted ureas were also more active than urea derivatives with cycloalkyl or hydroxyalkyl moieties. Semicarbazide 3a showed similar activity as PQ, while the other two semicarbazides were inactive. In general, bis-urea derivatives were less active than the analogues urea derivatives sharing the same scaffold, differing only in the spacer type. Out of 21 evaluated bisurea derivatives only p-Cl, m-CF3 phenyl derivative 4p, benzhydryl derivatives 4t and 4u and bis-PQ derivative 4s showed high activity, higher than the all three reference drugs.

primaquine ; urea ; bis-urea ; acylsemicarbazide ; amide ; antimycobacterial activity

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

244-244.

2017.

objavljeno

Podaci o matičnoj publikaciji

Book of Abstracts

Basarić , Nikola ; Namjesnik, Danijel ; Perković, Ivana ; Stepanić, Višnja

Zagreb: Hrvatsko kemijsko društvo

978-953-55232-8-4

Podaci o skupu

10th Joint Meeting on Medicinal Chemistry

poster

25.06.2017-28.06.2017

Srebreno, Hrvatska; Dubrovnik, Hrvatska

Povezanost rada

Kemija, Farmacija, Biologija

Poveznice